Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Melatonin, mitochondria and hypertension

Full text
Baltatu, Ovidiu C. [1] ; Amaral, Fernanda G. [2] ; Campos, Luciana A. [1] ; Cipolla-Neto, Jose [3]
Total Authors: 4
[1] Laureate Int Univ, Anhembi Morumbi Univ, CITE, 500 Dr Altino Bondensan Ave, BR-12247016 Sao Jose Dos Campos, SP - Brazil
[2] Univ Fed Sao Paulo, Dept Physiol, 862 Botucatu St, 5th Floor, BR-04023901 Sao Paulo, SP - Brazil
[3] Univ Sao Paulo, Dept Physiol, Inst Biomed Sci, Av Lineu Prestes 1524, Room 115-118, BR-05508000 Sao Paulo, SP - Brazil
Total Affiliations: 3
Document type: Review article
Source: CELLULAR AND MOLECULAR LIFE SCIENCES; v. 74, n. 21, p. 3955-3964, NOV 2017.
Web of Science Citations: 11

Melatonin, due to its multiple means and mechanisms of action, plays a fundamental role in the regulation of the organismal physiology by fine tunning several functions. The cardiovascular system is an important site of action as melatonin regulates blood pressure both by central and peripheral interventions, in addition to its relation with the renin-angiotensin system. Besides, the systemic management of several processes, melatonin acts on mitochondria regulation to maintain a healthy cardiovascular system. Hypertension affects target organs in different ways and cellular energy metabolism is frequently involved due to mitochondrial alterations that include a rise in reactive oxygen species production and an ATP synthesis decrease. The discussion that follows shows the role played by melatonin in the regulation of mitochondrial physiology in several levels of the cardiovascular system, including brain, heart, kidney, blood vessels and, particularly, regulating the renin-angiotensin system. This discussion shows the putative importance of using melatonin as a therapeutic tool involving its antioxidant potential and its action on mitochondrial physiology in the cardiovascular system. (AU)

FAPESP's process: 14/50457-0 - Melatonin and the control of energy metabolism: basic, clinical and epidemiological research
Grantee:José Cipolla Neto
Support type: Research Projects - Thematic Grants